Suppr超能文献

戈谢病患者成纤维细胞中的溶酶体膜完整性。

Lysosomal membrane integrity in fibroblasts derived from patients with Gaucher disease.

机构信息

Graduate School of Pharmaceutical Science, Kyoto University.

Faculty of Health Sciences, Hokkaido University.

出版信息

Cell Struct Funct. 2024 Jan 23;49(1):1-10. doi: 10.1247/csf.23066. Epub 2023 Dec 9.

Abstract

Gaucher disease (GD) is a recessively inherited lysosomal storage disorder characterized by a deficiency of lysosomal glucocerebrosidase (GBA1). This deficiency results in the accumulation of its substrate, glucosylceramide (GlcCer), within lysosomes. Here, we investigated lysosomal abnormalities in fibroblasts derived from patients with GD. It is noteworthy that the cellular distribution of lysosomes and lysosomal proteolytic activity remained largely unaffected in GD fibroblasts. However, we found that lysosomal membranes of GD fibroblasts were susceptible to damage when exposed to a lysosomotropic agent. Moreover, the susceptibility of lysosomal membranes to a lysosomotropic agent could be partly restored by exogenous expression of wild-type GBA1. Here, we report that the lysosomal membrane integrity is altered in GD fibroblasts, but lysosomal distribution and proteolytic activity is not significantly altered.Key words: glucosylceramide, lysosome, Gaucher disease, lysosomotropic agent.

摘要

戈谢病(GD)是一种常染色体隐性遗传的溶酶体贮积病,其特征为溶酶体β-葡糖苷酶(GBA1)缺乏。这种缺乏导致其底物葡萄糖脑苷脂(GlcCer)在溶酶体中积累。在这里,我们研究了来自 GD 患者的成纤维细胞中的溶酶体异常。值得注意的是,GD 成纤维细胞中的溶酶体的细胞分布和溶酶体蛋白水解活性基本不受影响。然而,我们发现,当暴露于溶酶体趋向性药物时,GD 成纤维细胞的溶酶体膜容易受到损伤。此外,外源性表达野生型 GBA1 可部分恢复溶酶体膜对溶酶体趋向性药物的敏感性。在这里,我们报告 GD 成纤维细胞中的溶酶体膜完整性发生改变,但溶酶体分布和蛋白水解活性没有明显改变。

关键词

葡萄糖脑苷脂、溶酶体、戈谢病、溶酶体趋向性药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/11496783/11012116dff2/csf_49_23066-f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验